DOI:
10.1055/s-00000021
Gesundheitsökonomie & Qualitätsmanagement
LinksClose Window
References
Eichmann F, Clouth J.
Budget impact of atypical neuroleptics in Germany: Model calculations based on the treatment of schizophrenia with Zyprexa.
Pharmacoeconomics 2004; 2: 3-16
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.